皮康一号方治疗寻常痤疮临床疗效观察

Effective observation on treating acne vulgaris with Pikang No.1

目的：观察皮康一号方治疗寻常痤疮的临床疗效及安全性。方法：选择南京市中医院皮肤科门诊患者345例,根据Pillsbury分类法,选择Ⅱ~Ⅲ度寻常痤疮患者,采用随机数表法将其分为治疗组（172例）和对照组（173例）。治疗组给予皮康一号方。对照组给予丹参酮胶囊,疗程为20周。根据疗效指数分4级进行疗效判定,并观察不良反应。结果：Ⅱ度寻常痤疮治疗组总有效率为81.91%;对照组总有效率为72.22%。Ⅲ度寻常痤疮治疗组总有效率为87.17%;对照组总有效率为69.88%。两组两型痤疮的疗效比较有显著性差异,P〈0.05。治疗组未见不良反应。结论：皮康一号方治疗寻常痤疮的疗效优于丹参酮胶囊。

Objective Clinical effects and safety of Pikang No.1 on acne vulgaris were observed. Methods： 345 cases of Ⅱ ～ Ⅲdegree acne vulgaris were selected according to Pillsbury classification method, and randomly divided into the treatment group （172 cases）and the control group （173 cases）. The treatment group was given Pikang No.1. The control group received Tanshinone capsules for 20weeks. Results： The total efficiency of Ⅱ degree acne vulgaris in the treatment group was 81.91%, and in the control group was 72.22%.The total efficiency of Ⅲ degree acne vulgaris was 87.17% in the treatment group, and 69.88% in the control group. There were sigificantdifferences, P〈0.05. There was no adverse reaction in the treatment group. Conclusion： Comparing with Tanshinone capsules, Pikang No.1was effective on acne vulgaris, with higher clinical efficacy and safety.